IP Library Granted Patent US 8,828,678
Granted Patent B2
US 8,828,678 · App. 12/927,497 · Granted Sep 9, 2014

Self-immolative probes for enzyme activity detection

Inventors: Maciej Szczepanik (Mount Sinai, NY); Irina V. Lebedeva (Bronx, NY); Yuejun Xiang (Hollis Hills, NY); Praveen Pande (Holbrook, NY); Wayne Forrest Patton (Dix Hills, NY)
Assignee: Enzo Life Sciences, Inc.
G09K11/06G01N2333/902C12Q1/26G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,828,678
App. No.
12/927,497
Granted
Sep 9, 2014
Kind
B2
Abstract

A compound comprising the structure: (SIG)-(SI-MOD) m . is provided in which SIG is a signaling molecule, SI is a self-immolative structure bound to SIG such that SIG has a reduced signal relative to the signal of SIG without SI, MOD is a moiety bound to SI that is subject to modification by an activator, and m is an integer from 1 to about 10. When MOD is modified by an activator, SI is destabilized and self-cleaved from SIG such that SIG generates an increased signal. Also provided are methods of determining whether a sample comprises an activator such as a nitroreductase, and methods of determining whether a mammalian cell is hypoxic using a compound of the formula (SIG)-(SI-MOD) m .

Claims (24)

1. A compound selected from:

wherein Z is a reducible nitrogen-containing group selected from the group consisting of a nitro group (NO 2 ), an azo group (—N═N), a hydrazo group (NH—NH), a nitroso group (NO), and a hydroxylamino group (NHOH), or an amino group with an electron-deficient moiety, or Z is amino group with an electron-deficient moiety selected from the group consisting of carbonyl (C═O), phosphoryl (PO 3 2− ) and sulfonyl (SO 3 − ); and

wherein L is nothing when Z is a reducible nitrogen-containing group, or L is an unsubstituted straight-chain, branched or cyclic alkyl, alkenyl or alkynyl group, a substituted straight-chain, branched or cyclic alkyl, alkenyl or alkynyl group wherein one or more C, CH or CH 2 groups are substituted by an O atom, N atom, S atom, or NH group, an unsubstituted or substituted aromatic group, or a linear or branched sequence of amino acids.

2. A compound of claim 1 wherein L is nothing and Z is NO 2 .

3. A method of determining whether a cell comprises a nitroreductase, the method comprising

(a) incubating the cell with a compound of claim 2 for a time and under conditions sufficient for the compound to enter the cell and be exposed to a nitroreductase if present in the cell; and

(b) determining if a signal greater than the signal generated by the compound when not exposed to a nitroreductase is generated,

wherein a greater signal indicates that the cell comprises the nitroreductase.

4. A method of determining whether a mammalian cell is hypoxic, the method comprising

(a) incubating the cell with a compound of claim 2 for a time and under conditions sufficient for the compound to enter the cell and be exposed to a nitroreductase if present in the cell, wherein the nitroreductase is indicative or hypoxia in the cell; and

(b) determining if a signal greater than the signal generated by the compound when not exposed to a nitroreductase is generated,

wherein a greater signal indicates that the cell is hypoxic.

5. A method of detecting a microorganism that comprises a nitroreductase, the method comprising

(a) incubating the microorganism with a compound of claim 2 for a time and under conditions sufficient for the compound to enter the cell and be exposed to a nitroreductase if present in the microorganism; and

(b) determining if a signal greater than the signal generated by the compound when not exposed to a nitroreductase is generated,

wherein a greater signal indicates that the microorganism comprises a nitroreductase.

6. A method of identifying nitroreductase in a sample, the method comprising

(a) incubating the sample a the compound of claim 2 , and

(b) determining if a signal greater than the signal generated by the compound when not exposed to a nitroreductase is generated,

wherein a greater signal indicates that the sample comprises a nitroreductase.

7. A method of detecting hydrosulfite in a sample, the method comprising

(a) combining the sample with a compound of claim 2 , then

(b) determining if a signal greater than the signal generated by the compound when not exposed to a nitroreductase is generated,

wherein a greater signal indicates that the sample comprises a hydrosulfite.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2011
From: SZCZEPANIK, MACIEJ; LEBEDEVA, IRINA V.; XIANG, YUEJUN; PANDE, PRAVEEN; PATTON, WAYNE FORREST
To: ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC.
Reel/Frame 026467/0343 →
Continuity (1)
Related Publication 20120122136A1 · May 17, 2012